Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
M

Microba Life Sciences Ltd
ASX:MAP

Watchlist Manager
Microba Life Sciences Ltd
ASX:MAP
Watchlist
Price: 0.057 AUD -1.72% Market Closed
Market Cap: AU$40.9m
Write Note Create Alert Ask AI

Wall St Price Targets

MAP Price Targets Summary
Microba Life Sciences Ltd

Wall Street analysts forecast MAP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MAP is 0.122 AUD with a low forecast of 0.121 AUD and a high forecast of 0.126 AUD.

MAP Lowest Forecast
Wall Street Target
AU$0.121
113% Upside
MAP Average Forecast
Wall Street Target
AU$0.122
115% Upside
MAP Highest Forecast
Wall Street Target
AU$0.126
121% Upside
Lowest Forecast
Price Target
0.121 AUD
113% Upside
Average Forecast
Price Target
0.122 AUD
115% Upside
Highest Forecast
Price Target
0.126 AUD
121% Upside
Microba Life Sciences Ltd Competitors:
Price Targets

Revenue
Forecast

40% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
40% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 5 years, the compound annual growth rate for Revenue has been 40%. The projected CAGR for the next 3 years is 24%.

What are analyst estimates?

Gross Profit
Forecast

39% / Year
Past Growth
38% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
39% / Year
Past Growth
38% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 5 years, the compound annual growth rate for Gross Profit has been 39%. The projected CAGR for the next 3 years is 38%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
18%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
18%
Average Beat

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

What are analyst estimates?

Continue MAP Research

Summary
MAP intrinsic value, competitors valuation, and company profile.
DCF Valuation
MAP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MAP stock valuation using valuation multiples.
Wall St Estimates
MAP price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MAP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Microba Life Sciences Ltd listings:
F • EUR
F3Y
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is MAP's stock price target?
Price Target
0.122 AUD

According to Wall Street analysts, the average 1-year price target for MAP is 0.122 AUD with a low forecast of 0.121 AUD and a high forecast of 0.126 AUD.

What is the Revenue forecast for Microba Life Sciences Ltd?
Projected CAGR
24%

Over the last 5 years, the compound annual growth rate for Revenue has been 40%. The projected CAGR for the next 3 years is 24%.

What is the Gross Profit forecast for Microba Life Sciences Ltd?
Projected CAGR
38%

Over the last 5 years, the compound annual growth rate for Gross Profit has been 39%. The projected CAGR for the next 3 years is 38%.

Back to Top
ALPHA SPREAD
Follow us
Join 353,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett